Business Standard

Interim trial results show Sputnik V Covid-19 vaccine 92% effective: Russia

Pfizer Inc and BioNTech said on Monday their shot was more than 90% effective

Coronavirus, vaccine, covid
Premium

Moscow rushes to keep pace with Western drugmakers in the race for a shot

Reuters New Delhi
Russia's Sputnik V vaccine is 92 per cent effective at protecting people from Covid-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.

Russia's results are only the second from a late-stage human trial, following on swiftly from data released on Monday by Pfizer Inc and BioNTech, which said their shot was also more than 90 per cent effective.

While experts said the Russian data was encouraging and reinforced the idea the pandemic could be halted by vaccines, they warned that the results

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in